Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes

Citations

WEB OF SCIENCE

27
Citations

SCOPUS

32

초록

Renal cell carcinoma (RCC) in patients with von Hippel Lindau (VHL) disease tends to be multifocal, bilateral, and recur or develop new tumors after removal. These characteristics make treating hereditary RCCs difficult for urologists or radiologists compared to treating a sporadic RCC. Radiofrequency ablation (RFA) is a minimally-invasive treatment for small hereditary RCCs associated with a low complication rate and a minimal decrease in renal function. No RFA guidelines have been established about what to treat and when and how to ablate RCCs in patients with VHL disease. Besides, reports on complications and treatment outcomes in this patient group are rare. The purpose of this review is to discuss the indications, techniques, complications, and outcomes of RFA in treating RCC in patients with VHL disease.

키워드

Radiofrequency ablation; renal cell carcinoma; von Hippel Lindau disease; complication; outcome; CYST PSEUDOENHANCEMENT; PARTIAL NEPHRECTOMY; COLLECTING SYSTEM; THERMAL ABLATION; MULTIDETECTOR CT; SPARING SURGERY; CRYOABLATION; TUMORS; MANAGEMENT; MASSES
제목
Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes
저자
Park, Byung Kwan; Kim, Chan Kyo; Park, Sung Yoon; Shen, Shu-Huei
DOI
10.1177/0284185113475441
발행일
2013-05
유형
Review
저널명
Acta Radiologica
권
54
호
4
페이지
418 ~ 427